1,023
Views
46
CrossRef citations to date
0
Altmetric
Letter to the Editors

Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses

, , , , , & show all
Pages 1-12 | Received 01 Dec 2015, Accepted 23 Feb 2016, Published online: 25 Jan 2019

  • JungDS,FarmakiotisD,JiangYet al.Uncommon Candida species fungemia among cancer patients, Houston, Texas, USA.Emerg Infect Dis2015; 21:1942–1950.
  • Cendejas-BuenoE,KoleckaA,Alastruey-IzquierdoAet al.Reclassification of the Candida haemulonii complex as Candida haemuloniiC. haemulonii group I), C. duobushaemulonii sp. nov.C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts.J Clin Microbiol2012; 50:3641–3651.
  • RuanSY,KuoYW,HuangCTet al.Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes.Int J Antimicrob Agents2010; 35:85–88.
  • RamosLS,Figueiredo-CarvalhoMH,BarbedoLSet al.Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil.J Antimicrob Chemother2015; 70:111–115.
  • ChowdharyA,SharmaC,DuggalSet al.New clonal strain of Candida auris, Delhi, India.Emerg Infect Dis2013; 19:1670–1673.
  • MuroMD,MottaFdeA,BurgerMet al.Echinocandin resistance in two Candida haemulonii isolates from pediatric patients.J Clin Microbiol2012; 50:3783–3785.
  • KimMN,ShinJH,SungHet al.Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.Clin Infect Dis2009; 48:e57–e61.
  • KhanZU,Al-SweihNA,AhmadSet al.Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.J Clin Microbiol2007; 45:2025–2027.
  • VosP,HogersR,BleekerMet al.AFLP: a new technique for DNA fingerprinting.Nucleic Acids Res1995; 23:4407–4414.
  • Clinical Laboratory Standards Institute (CLSI)Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts (approved standard M27-A3).3rd edn.Wayne, PA, USA: National Committee for Clinical Laboratory Standards; 2008.Available athttp://shop.clsi.org/microbiology-documents/M27.html.
  • ChowdharyA,Anil KumarV,SharmaCet al.Multidrug-resistant endemic clonal strain of Candida auris in India.Eur J Clin Microbiol Infect Dis2014; 33:919–926.
  • KullbergBJ,ArendrupMC.Invasive candidiasis.N Engl J Med2015; 373:1445–1456.
  • PfallerMA,DiekemaDJ,GibbsDLet al.Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.J Clin Microbiol2010; 48:1366–1377.
  • OberoiJK,WattalC,GoelNet al.Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.Indian J Med Res2012; 136:997–1003.
  • KathuriaS,SinghPK,SharmaCet al.Multidrug resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI Broth Microdilution, and Etest method.J Clin Microbiol2015; 53:1823–1830.
  • ArendrupMC,BoekhoutT,AkovaMet al.ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.Clin Microbiol Infect2014; 20:76–98.